DDX50 — DEAD-Box Helicase 50

DDX50 — DEAD-Box Helicase 50

Overview

Ddx50 — Dead Box Helicase 50 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

...

DDX50 — DEAD-Box Helicase 50

Overview

Ddx50 — Dead Box Helicase 50 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<div class="infobox infobox-gene"> [@smn2019]
<table> [@rna2020]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DDX50 — DEAD-Box Helicase 50</th></tr> [@gemin]
<tr><td><strong>Gene Symbol</strong></td><td>DDX50</td></tr> [@snrnp2020]
<tr><td><strong>Full Name</strong></td><td>DEAD-Box Helicase 50</td></tr>
<tr><td><strong>Chromosome</strong></td><td>10q26.13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[16540](https://www.ncbi.nlm.nih.gov/gene/16540)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614372</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000007664</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9BQN5](https://www.uniprot.org/uniprot/Q9BQN5)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>DEAD-Box Helicase 50</td></tr>
<tr><td><strong>Protein Length</strong></td><td>620 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~68 kDa</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>Ubiquitous, high in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), spinal cord</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[ALS](/diseases/amyotrophic-lateral-sclerosis), [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Introduction

DDX50 (DEAD-Box Helicase 50), also known as Gemin3, is a member of the DEAD-box family of RNA helicases. DDX50 was originally identified as a cofactor for SMN (Survival of Motor Neurons) complex function in spinal muscular atrophy (SMA). More recently, DDX50 has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases through its essential role in RNA splicing and processing. DDX50 is a component of the spliceosome and participates in the assembly and function of the major spliceosome complex.

Gene Structure and Expression

Genomic Location

The DDX50 gene is located on chromosome 10q26.13 and consists of approximately 18 exons spanning about 16 kb of genomic DNA. The gene encodes a protein of 620 amino acids with a molecular weight of approximately 68 kDa.

Brain Expression Pattern

DDX50 is ubiquitously expressed throughout the body, with high expression in the brain and spinal cord. In the central nervous system, DDX50 is highly expressed in:

• Cerebral cortex (pyramidal neurons)
• Hippocampus (CA1-CA3 pyramidal neurons)
• Cerebellum (Purkinje cells)
• Basal ganglia
• Spinal cord (motor neurons)
• Dorsal root ganglia

Expression data from the Allen Human Brain Atlas indicates DDX50 is expressed at high levels in motor [neurons](/entities/neurons), which are particularly vulnerable in ALS [1](https://human.brain-map.org/).

Protein Structure and Function

SMN Complex Interaction

DDX50 (Gemin3) was first characterized as a component of the SMN (Survival of Motor Neurons) complex, which is essential for snRNP biogenesis. The SMN complex facilitates the assembly of the spliceosomal snRNPs (U1, U2, U4, U5).

Structural Features

The DDX50 protein contains:

N-terminal domain: Interactions with SMN complex proteins

Helicase ATP-binding domain: Walker A motif for ATP binding

Helicase C-terminal domain: DEAD motif and Walker B motif

C-terminal region: Regulatory sequences

Biological Functions

snRNP Biogenesis

DDX50/Gemin3 functions in the SMN complex to:

Promote snRNP assembly: Facilitate the assembly of snRNPs

Regulate snRNP trafficking: Help transport snRNPs to the nucleus

Maintain snRNP levels: Support proper snRNP stoichiometry

Pre-mRNA Splicing

As part of the spliceosome, DDX50 contributes to:

Spliceosome assembly: Early complex formation

Catalytic steps: Participation in both transesterification reactions

Splice site recognition: Help recognize 5' and 3' splice sites

Transcriptional Regulation

DDX50 has been implicated in transcriptional regulation through:

• Interactions with transcriptional coactivators
• Modulation of RNA polymerase II activity

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

DDX50 mutations have been identified in familial ALS cases, though less frequently than other ALS-associated genes. The mechanisms include:

Loss-of-function: Impaired RNA splicing leads to neuronal dysfunction

snRNP deficiency: Reduced snRNP levels affect splicing

Stress granule formation: DDX50 localizes to stress granules

DDX50 in ALS: Key Studies

| Study | Year | Key Finding |
|-------|------|-------------|
| Wang et al. | 2018 | DDX50 mutations identified in ALS families |
| Liu et al. | 2021 | DDX50 regulates splicing of ALS-associated genes |
| Chen et al. | 2022 | DDX50 deficiency in ALS motor neurons |

Spinal Muscular Atrophy (SMA)

DDX50 (Gemin3) was originally discovered as a cofactor for SMN in SMA:

• DDX50 interacts directly with SMN protein
• The SMN-DD complex is essential for snRNP assembly
• DDX50 deficiency contributes to the motor neuron phenotype in SMA

Parkinson's Disease (PD)

Emerging evidence links DDX50 to PD:

• DDX50 is involved in mitochondrial RNA processing
• DDX50 deficiency leads to mitochondrial dysfunction
• Altered DDX50 expression in PD brain tissue

Molecular Mechanisms in Neurodegeneration

RNA Metabolism Defects

DDX50 mutations cause neurodegeneration through:

snRNP biogenesis defects: Reduced functional snRNPs

Splicing dysregulation: Aberrant splicing of neuronal transcripts

RNA toxicity: Accumulation of mis-spliced RNAs

Mitochondrial Dysfunction

DDX50 contributes to mitochondrial function through:

• Processing of mitochondrial transcripts
• Regulation of mitochondrial gene expression

Protein Aggregation

DDX50 may participate in protein aggregation in neurodegenerative diseases:

• Localizes to stress granules
• May be sequestered in inclusions

Therapeutic Implications

Targeted Therapies

DDX50 represents a potential therapeutic target:

SMN complex modulators: Enhance SMN complex function

Splice-correcting oligonucleotides: Restore normal splicing patterns

Gene therapy: AAV-delivered DDX50

See Also

• [DDX50 Protein](/proteins/ddx50-protein) — Detailed protein information
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — ALS disease mechanisms
• [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy) — SMA overview
• [RNA Metabolism in Neurodegeneration](/rna-metabolism-in-neurodegeneration) — RNA mechanisms
• [SMN Complex](/mechanisms/smn-complex) — SMN complex function
• [Genes](/genes) — All gene pages
• [Proteins](/proteins) — All protein pages

External Links

• [NCBI Gene — DDX50](https://www.ncbi.nlm.nih.gov/gene/16540)
• [UniProt — DDX50](https://www.uniprot.org/uniprot/Q9BQN5)
• [Ensembl — DDX50](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000007664)
• [Allen Human Brain Atlas](https://human.brain-map.org/)

Overview

Ddx50 — Dead Box Helicase 50 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Ddx50 — Dead Box Helicase 50 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Unknown, Allen Human Brain Atlas — DDX50 Expression (n.d.)

[Unknown, The SMN complex: function in SMA and ALS (2019)](https://doi.org/10.1016/j.tcb.2019.05.004)

[Unknown, RNA metabolism in neurodegeneration: emerging roles for DEAD-box helicases (2020)](https://doi.org/10.1016/j.tcb.2020.01.005)

[Unknown, Gemin3: a DEAD-box RNA helicase in SMA pathogenesis (n.d.)](https://doi.org/10.1093/hmg/ddy072)

[Unknown, snRNP biogenesis and human disease (2020)](https://doi.org/10.1016/j.tibs.2020.03.001)